SinoMab BioScience Limited (HKG:3681)
Hong Kong · Delayed Price · Currency is HKD 1.890
+0.100 (5.59%)
Feb 13, 2026, 4:08 PM HKT
SinoMab BioScience Market Cap
SinoMab BioScience has a market cap or net worth of 2.48 billion as of February 13, 2026. Its market cap has increased by 125.10% in one year.
Market Cap
2.48B
Enterprise Value
2.77B
Revenue
6.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.89
Market Cap Chart
Since November 12, 2019, SinoMab BioScience's market cap has decreased from 6.04B to 2.48B, a decrease of -58.89%. That is a compound annual growth rate of -13.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.48B | 33.58% |
| Dec 31, 2025 | 1.86B | 56.14% |
| Dec 31, 2024 | 1.19B | -31.56% |
| Dec 29, 2023 | 1.74B | -7.18% |
| Dec 30, 2022 | 1.87B | -34.91% |
| Dec 31, 2021 | 2.88B | -37.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioDlink International Company | 3.27B |
| Clover Biopharmaceuticals | 2.93B |
| Jiangsu Recbio Technology | 2.93B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 2.42B |
| Antengene Corporation | 2.37B |
| Frontage Holdings | 2.07B |
| Mabpharm | 2.06B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.93B |